STAVZOR

LOE Approaching

valproic acid

NDAORALCAPSULE, DELAYED RELEASE
Approved
Jul 2008
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
20

Clinical Trials (5)

NCT07166393Phase 2/3Not Yet Recruiting

Valproic AcId for Traumatic BRAin INjury Trial

Started May 2026
432 enrolled
Moderate Traumatic Brain Injury (TBI)Severe Traumatic Brain Injury
NCT06729970Phase 1Completed

A Study to Evaluate the Effects of Lithium, Valproic Acid, and Lamotrigine on the Pharmacokinetics of KarXT and Effects of KarXT on the Pharmacokinetics of Lithium, Valproic Acid, and Lamotrigine in Healthy Participants

Started Dec 2024
133 enrolled
Healthy Volunteers
NCT04531592Phase 2Withdrawn

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Liver Transplant Patients

Started Jan 2022
0
Acute Kidney InjuryIschemia Reperfusion Injury
NCT04531579Phase 2Withdrawn

Valproic Acid (VPA) for Acute Kidney Injury (AKI) in Trauma Patients

Started Jan 2022
0
Acute Kidney InjuryIschemia Reperfusion Injury
NCT03385525Phase 1Completed

Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074

Started Sep 2017
30 enrolled
Drug Interaction
Data Sources
  • Drug label: DailyMed / FDA
  • Clinical trials: ClinicalTrials.gov
  • Patent data: FDA Orange Book
  • Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.